This new establishment on Florida’s Space Coast elevates the company’s statewide dispensary tally to 70 and its national total to 159.
STAMFORD, Conn., Dec. 4, 2025 — (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a prominent international supplier of consumer cannabis products, today announced the inauguration of its newest dispensary in Cape Canaveral, Florida, situated at 6710 N Atlantic Avenue. This fresh establishment underscores Curaleaf’s sustained growth within the Sunshine State, raising its dispensary count to 70 in Florida and 159 across the nation.
Curaleaf Cape Canaveral is set to provide patients with a diverse selection of premium products from the Company’s premier collection of brands, featuring Anthem pre-rolls, Grassroots Dark Heart, Select Briq, Select ACE, and Reef. Patients can anticipate finding high-quality flower, vape, and edible choices, all tailored to address a range of wellness and lifestyle requirements.
Positioned conveniently close to the beachfront, and in proximity to residential communities and local enterprises, Curaleaf Cape Canaveral offers an inviting and readily available retail environment for both new and established patients. The dispensary will operate Monday through Saturday from 9:00 a.m. to 8:30 p.m. and on Sunday from 10:00 a.m. to 7:00 p.m.
“Florida continues to be a crucial expanding market for Curaleaf, and we are pleased to further broaden the availability of safe, high-quality cannabis for medical patients throughout the state,” stated Boris Jordan, Chairman and CEO of Curaleaf. “Cape Canaveral offers an opportunity to deepen our ties with the Florida community and to reiterate our dedication to fostering innovation, promoting education, and ensuring responsible access within the cannabis industry.”
In commemoration of this launch, Curaleaf will hold a grand opening ceremony and ribbon-cutting event on Friday, December 12, which will include giveaways, exclusive promotions, and complimentary items with purchases. Further details regarding Curaleaf’s establishments, patient support, and product selections can be found at .
About Curaleaf Holdings, Inc.
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (“Curaleaf”) stands as a prominent international supplier of consumer cannabis products, driven by its aim to improve lives through cultivating, distributing, and championing the plant’s potential. As a rapidly expanding cannabis firm recognized for its excellence, proficiency, and dependability, the Company and its brands—including Curaleaf, Select, Grassroots, Find, Anthem, and The Hemp Company—deliver unparalleled service, diverse product choices, and widespread accessibility across both medical and adult-use markets. Curaleaf International benefits from robust involvement across all supply chain phases. Its distinctive distribution infrastructure spanning Europe, Canada, and Australasia integrates groundbreaking scientific inquiry with advanced cultivation, extraction, and manufacturing processes. Curaleaf is publicly traded on the Toronto Stock Exchange under the ticker CURA and on the OTCQX market with the symbol CURLF. For additional information, please visit .
Forward Looking Statements
This media advisory includes forward-looking statements and forward-looking information as defined by relevant securities legislation. These declarations pertain to prospective occurrences or future operational outcomes. Any declarations not pertaining to past events could be considered forward-looking declarations or data. Generally, forward-looking statements and information may be recognized through terms predictive of future activity like “plans”, “expects” or “proposed”, “is expected”, “intends”, “anticipates”, or “believes”, or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. Specifically, and without restricting the scope, this announcement presents forward-looking declarations and details regarding the inauguration of a dispensary in Cape Canaveral, FL. Such forward-looking statements and information mirror management’s present convictions and stem from presumptions made by, and intelligence presently accessible to, the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and vulnerable to identified and unidentified risks and ambiguities that might lead to actual outcomes varying substantially from those explicitly stated or implicitly suggested by such statements. Additional information about these assumptions and uncertainties can be found within “Risk Factors and Uncertainties” in the Company’s latest annual information form submitted on March 3, 2025, which is accessible via the Company’s SEDAR profile at , and through other submissions the Company has made or may make with relevant securities regulators henceforth. Forward-looking statements contained herein are made only as to the date of this press release and we assume no responsibility to amend or update any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We advise investors against placing undue dependence on the forward-looking statements contained in this press release. The Toronto Stock Exchange has not reviewed, approved or disapproved the content of this news release.
Investor Contact:
Curaleaf Holdings, Inc.
Camilo Lyon, Chief Investment Officer
Media Contact:
MATTIO Communications
SOURCE Curaleaf Holdings, Inc.